Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) was upgraded by investment analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Wednesday.
A number of other research analysts also recently issued reports on the stock. Oppenheimer downgraded shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th. B. Riley initiated coverage on shares of Tactile Systems Technology in a report on Thursday, September 26th. They issued a “buy” rating and a $23.00 target price on the stock. Finally, BTIG Research lowered Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th.
View Our Latest Stock Analysis on Tactile Systems Technology
Tactile Systems Technology Stock Down 0.1 %
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of TCMD. Paradigm Capital Management Inc. NY increased its holdings in Tactile Systems Technology by 90.1% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,183,800 shares of the company’s stock valued at $14,135,000 after buying an additional 561,073 shares during the period. Essex Investment Management Co. LLC bought a new stake in Tactile Systems Technology in the third quarter valued at about $1,803,000. Los Angeles Capital Management LLC acquired a new position in Tactile Systems Technology in the second quarter worth about $1,187,000. Federated Hermes Inc. raised its position in Tactile Systems Technology by 26.5% in the second quarter. Federated Hermes Inc. now owns 433,660 shares of the company’s stock worth $5,178,000 after purchasing an additional 90,960 shares in the last quarter. Finally, Wasatch Advisors LP lifted its stake in Tactile Systems Technology by 9.8% during the third quarter. Wasatch Advisors LP now owns 727,194 shares of the company’s stock worth $10,624,000 after purchasing an additional 64,684 shares during the period. 83.43% of the stock is owned by institutional investors and hedge funds.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Recommended Stories
- Five stocks we like better than Tactile Systems Technology
- Stock Splits, Do They Really Impact Investors?
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Trading Halts Explained
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Stock Average Calculator
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.